Major Scope
- Cardiovascular Case Reports
- Oncology Case Reports
- Surgical Case Reports
- Gastroenterological Case Reports
- Neurological Case Reports
- Dermatological Case Reports
- Respiratory Case Reports
- Obstetrics/Gynecology Case Reports
- Nephrology Case Reports
- Immunology Case Reports
- Paediatric Case Reports
- Orthopedics Case Reports
- Dental Case Reports
Abstract
Citation: Ann Clin Case Rep. 2016;1(1):1040.DOI: 10.25107/2474-1655.1040
Terlipressin-Induced Irreversible Severe Skin Necrosis: A Dreadful Complication
Cleva RD, Santarém OLDA and Herman P
Department of Gastroenterology, University of São Paulo Medical School, Brazil
*Correspondance to: Paulo Herman
PDF Full Text Case Report | Open Access
Abstract:
Terlipressin (triglycyl lysine vasopressin), a synthetic analogue of vasopressin, has been employed in the last years for the treatment of upper digestive bleding from esophagogastric varices and for hepatorenal syndrome. Several adverse effects have been reported, all reversible after dose reduction or drug interruption. The authors report two rare cases of irreversible severe skin necrosis induced by terlipressin infusion.
Keywords:
Terlipressin; Portal hypertension; Digestive bleeding; Hepatorenal syndrome
Cite the Article:
Cleva RD, Santarém OLDA, Herman P. Terlipressin-Induced Irreversible Severe Skin Necrosis: A Dreadful Complication. Ann Clin Case Rep. 2016; 1: 1040.
Journal Basic Info
- Impact Factor: 5.253*
- H-Index: 6
- ISSN: 2474-1655
- DOI: 10.25107/2474-1655
- PubMed NLM ID: 101702800